Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ·Healthcare·Biotechnology
$12.54
-0.56%
Mkt Cap $261.88M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$48.20
Range $20.00 – $87.00
Implied Upside
+284.4%
Consensus $48.20 vs current $12.54
NASDAQ·Healthcare·Biotechnology
$12.54
-0.56%
Mkt Cap $261.88M
Buy
1
Hold
0
Sell
0
Price Target (5 analysts)
$48.20
Range $20.00 – $87.00
+284.4%
Consensus $48.20 vs current $12.54